Table 3. Scope of Disclosure of R&D Payments in Countries With Public Regulation .

Country	France	Portugal	Turkey	Denmark	Slovakia
Name of regulationa	Law No. 2011-2012 (Law Bertrand)	Decree Law 20/2013 and 128/2013	Regulation on Promotional Activities of Medicinal Products for Human Use 2015	Health Act of 2014, Executive Order No. 1153	Act No. 362/2011 on Medicines and Medical Devices
Overseeing authority	Ministry of Social Affairs and Health	National Authority of Medicines and Health Products	Ministry of Health	Danish Medicines Agency	National Health Information Center
Provisions Affecting the Scope of Disclosure Directly
Categorisation of R&D payments	Disclosed within three major payment categories – advantages (benefits); contracts (agreements); payments related to contracts (remuneration)	Fall within other payment categories, including “subsidies, sponsorships, grants or any other value, good or right granted or received”	No list of disclosed payment categories is provided	One of disclosed “professional affiliations” with industry	Falls under “financial and in-kind benefits”
Activities associated with R&D payments	Scientific research; consultancy contracts with scientific researchers; contracts regarding scientific expertise; research; clinical study of a biological material	Clinical studies and trials	N/A	Research	Clinical trials, non-intervention clinical studies, post-registration studies of human drug safety, market research
List of activities associated with R&D payments	Exhaustive	Indicative	N/A	Exhaustive	Exhaustive
Provisions Affecting the Scope of Disclosure Indirectly
Funders	Pharma, medical device, in vitro diagnostic medical device, cosmetics, veterinary products, tattoo products, associated providers	Pharma, medical device, other (unspecified)	Pharma	Pharma, medical device, and specialty stores with medical equipment	Pharma
Recipients	Individual and organisational	Individual and organisational	Individual and organisational	Individual	Individual and organisational (only healthcare providers)
Exempted payments	Below €10 including taxes	Below €60	Below 10% of the minimum monthly salary	No	No

Abbreviations: N/A, not available; R&D, research and development.

^aThe dates provided in this row refer to when public regulation of payment disclosure was first introduced. If public regulation of payment disclosure forms part of a larger piece of legislation, we specify, where appropriate, if the regulation of payment disclosure was introduced as a change to already existing legislation. The dates reported here do not cover changes to, or refinements of, legislative provisions focusing on payment disclosure.